1 |
Degli-Esposti MA, Dougall WC, Smolak PJ, Waugh JY, Smith CA, Goodwin RG (1997): The novel receptor TRAIL-R4 induces NF- B and protects against TRAIL-mediated apoptosis, yet retains an incomplete death domain. Immunity 7:813-820
DOI
ScienceOn
|
2 |
Franke TF, Hornik CP, Segev L, Shostak GA, Sugimoto C (2003): PI3K/ Akt and apoptosis: size matters. Oncogene 22:8983-8998
DOI
ScienceOn
|
3 |
Ghosh S, Karin M (2002): Missing pieces in the NF- B puzzle. Cell 109:S81-S96
DOI
ScienceOn
|
4 |
Leverkus M, Sprick MR., Wachter T, Mengling T, Baumann B, Serfling E, Brocker EB, Goebeler M, Neumann M Walczak H (2003): Proteasome inhibition results in TRAIL sensitization of primary keratinocytes by removing the resistance-mediating block of effector caspase maturation. Mol Cell Biol 23:777-790
DOI
ScienceOn
|
5 |
Milani D, Zauli G, Rimondi E, Celeghini C, Marmiroli S, Narducci P, Capitani S, Secchiero P (2003): Tumour necrosis factor-related apoptosis-inducing ligand sequentially activates pro-survival and pro-apoptotic pathways in SK-N-MC neuronal cells. J Neurochem 86: 126-135
DOI
ScienceOn
|
6 |
Pearson G, Robinson F, Beers Gibson T, Xu BE, Karandikar M, Berman K, Cobb MH (2001): Mitogen-activated protein (MAP) kinase pathways: regulation and physiological functions. Endocr Rev 22:153-183
DOI
ScienceOn
|
7 |
Schneider P, Thome M, Burns K, Bodmer JL, HofmannK, Kataoka T, Holler N, Tschopp J (1997): TRAIL receptors 1 (DR4) and 2 (DRS) signal FADD-dependent apoptosis and activate NF- B. Immunity 7:831-836
DOI
ScienceOn
|
8 |
Sheridan JP, Marsters SA, Pitti RM, Gurney A, Skubatch M, Baldwin D, Ramakrishnan L, Gray CL, Baker K, Wood WI, Goddard AD, Godowski P, Ashkenazi A (1997) Control of TRAIL-induced apoptosis by a family of signaling and decoy receptors. Science 277:818-821
DOI
PUBMED
ScienceOn
|
9 |
Soldani C, Scovassi AI (2002): Poly(ADP-ribose) polymerase-1 cleavage during apoptosis: an update. Apoptosis 7:321-328
DOI
ScienceOn
|
10 |
Thome M, Schneider P, Hofmann K, Fickenscher H, Meinl E, Neipel F, Mattmann C, Burns K, Bodmer JL, Schroter M, Scaffidi C, Krammer PH, Peter ME, Tschopp J (1997): Viral FLICE-inhibitory proteins (FLIPs) prevent apoptosis induced by death receptors. Nature 386:517-521
DOI
ScienceOn
|
11 |
Wiley SR, Schooley K, Smolak PJ, Din WS, Huang CP, Nicholl JK, Sutherland GR, Smith TD, Rauch C, Smith CA, Goodwin RG (1995): Identification and characterization of a new member of the TNF family that induces apoptosis. Immunity 3:673-682
DOI
ScienceOn
|
12 |
Franco AV, Zhang XD, Van Berkel E, Sanders JE, Zhang XY, Thomas WD, Nguyen T, Hersey P (2001): The role of NF- B in TNF-related apoptosis-inducing ligand (TRA-IL)-induced apoptosis of melanoma cells. J Immunol 166:5337-5345
DOI
|
13 |
Trauzold A, Wermann H, Arlt A, Schutze S, Schafer H, Oestern S, Roder C, Ungefroren H, Lampe E, Heinrich M, Walczak H, Kalthoff H (2001): CD95 and TRAIL receptor-mediated activation of protein kinase C and NF- B contributes to apoptosis resistance in ductal pancreatic adenocarcinoma cells. Oncogene 20:4258-4269
DOI
ScienceOn
|
14 |
Fiorucci S, Distrutti E, Ajuebor MN, Mencarelli A, Mannucci R, Palazzetti B, Del Soldato P, Morelli A, Wallace JL (2001): NO-mesalamine protects colonic epithelial cells against apoptotic damage induced by proinflammatory cytokines. Am J Physiol Gastrointest Liver Physiol 281:G654-G665
DOI
|
15 |
Secchiero P, Melloni E, Heikinheimo M, Mannisto S, Di Pietro R, Iacone A, Zauli G (2004): TRAIL regulates normal erythroid maturation through an ERK-dependent pathway. Blood 103:517-522
DOI
ScienceOn
|
16 |
Bamberger AM, Schulte HM, Thuneke I, Erdmann I, Bamberger CM, Asa SL (1997): Expression of the apoptosis-inducing Fas ligand (FasL) in human first and third trimester placenta and choriocarcinoma cells. J Clin Endocrinol Metab 82:3173-3175
DOI
ScienceOn
|
17 |
Phillips TA, Ni J, Hunt JS (2001): Death-inducing tumour necrosis factor (TNF) superfamily ligands and receptors are transcribed in human placentae, cytotrophoblasts, placental macrophages and placental cell lines. Placenta 22:663-672
DOI
ScienceOn
|
18 |
Ravi R, Bedi GC, Engstrom LW, Zeng Q, Mookerjee B, Gelinas C, Fuchs EJ, Bedi A (2001): Regulation of death receptor expression and TRAIL/Apo2L-induced apoptosis by NF- B. Nat Cell Biol 3:409-416
DOI
ScienceOn
|
19 |
Secchiero P, Gonelli A, Carnevale E, Milani D, Pandolfi A, ZelIa D, Zauli G (2003): TRAIL promotes the survival and proliferation of primary human vascular endothelial cells by activating the Akt and ERK pathways. Circulation 107:2250-2256
DOI
ScienceOn
|
20 |
Chou AH, Tsai HF, Lin LL, Hsieh SL, Hsu PI, Hsu PN (2001): Enhanced proliferation and increased IFN-gamma production in T cells by signal transduced through TNF-related apoptosis-inducing ligand. J Immunol 167:1347-1352
DOI
|
21 |
Hu WH, Johnson H, Shu HB (1999): Tumor necrosis factor-related apoptosis-inducing ligand receptors signal NF- B and JNK activation and apoptosis through distinct pathways. J Biol Chem 274:30603-30610
DOI
|
22 |
Ashkenazi A, Dixit VM (1998): Death receptors: signaling and modulation. Science 281:1305-1308
DOI
PUBMED
ScienceOn
|
23 |
Chaudhary PM, Eby M, Jasmin A, Bookwalter A, Murray J, Hood L (1997): Death receptor 5, a new member of the TNFR family, and DR4 induce FADD-dependent apoptosis and activate the NF- B pathway. Immunity 7: 821-830
DOI
ScienceOn
|
24 |
Lazebnik YA, Kaufmann SH, Desnoyers S, Poirier GG, Earnshaw WC(1994): Cleavage of poly(ADP-ribose) polymerase by a proteinase with properties like ICE. Nature 371:346-347
DOI
ScienceOn
|
25 |
Li Q Verma IM (2002): NF- B regulation in the immune system. Nat Rev Immunol 2:725-734
DOI
ScienceOn
|
26 |
Ka H, Hunt JS (2003): Temporal and spatial patterns of expression of inhibitors of apoptosis in human placentas. Am J Pathol 163:413-422
DOI
|
27 |
Walczak H, Miller RE, Ariail K, Gliniak B, Griffith TS, Kubin M, Chin W, Jones J, Woodward A, Le T, Smith C, Smolak P, Goodwin RG, Rauch CT, Schuh JC, Lynch DH (1999): Tumoricidal activity of tumor necrosis factor-related apoptosis-inducing ligand in vivo. Nat Med 5:157-163
DOI
ScienceOn
|
28 |
Chen HL, Yang YP, Hu XL, Yelavarthi KK, Fishback JL, Hunt JS (1991): Tumor necrosis factor alpha mRNA and protein are present in human placental and uterine cells at early and late stages of gestation. Am J Pathol 139:327-335
|
29 |
Locksley RM, Killeen N, Lenardo MJ (2001): The TNF and TNF receptor superfamilies: integrating mammalian biology. Cell 104:487-501
DOI
ScienceOn
|
30 |
Mariani SM, Krammer PH (1998): Differential regulation of TRAIL and CD95 ligand in transformed cells of the T and B lymphocyte lineage. Eur J Immunol 28:973-982
DOI
ScienceOn
|
31 |
Ashkenazi A, Pai RC, Fong S, Leung S, Lawrence DA, Marsters SA, Blackie C, Chang L, McMurtrey AE, Hebert A, DeForge L, Koumenis IL, Lewis D, Harris L, Bussiere J, Koeppen H, Shahrokh Z, Schwall RH (1999): Safety and antitumor activity of recombinant soluble Apo2 ligand. J Clin Invest 104:155-162
DOI
ScienceOn
|
32 |
Phillips TA, Ni J, Pan G, Ruben SM, Wei YF, Pace JL, Hunt JS (1999): TRAIL (Apo-2L) and TRAIL receptors in human placentas: implications for immune privilege. J Immunol 162:6053-6059
|
33 |
Kita N, Mitsushita J, Ohira S, Takagi Y, Ashida T, Kanai M, Nikaido T, Konishi I (2003): Expression and activation of MAP kinases, ERK1/2, in the human villous trophoblasts. Placenta 24:164-172
DOI
ScienceOn
|
34 |
Oya M, Ohtsubo M Takayanagi A, Tachibana M, Shimizu N, Murai M (2001): Constitutive activation of nuclear factor-kappaB prevents TRAIL-induced apoptosis in renal cancer cells. Oncogene 20:3888-3896
DOI
ScienceOn
|
35 |
Pitti RM, Marsters SA, Ruppert S, Donahue CJ, Moore A, Ashkenazi A (1996): Induction of apoptosis by Apo-2 ligand, a new member of the tumor necrosis factor cytokine family. J Biol Chem 271:12687-12690
DOI
ScienceOn
|
36 |
Bernard D, Quatannens B, Vandenbunder B, Abbadie C (2001): Rel/NF- B transcription factors protect against tumor necrosis factor (TNF)-related apoptosis-inducing ligand (TRAIL)-induced apoptosis by up-regulating the TRAIL decoy receptor DcR1. J Biol Chem 276:27322-27328
DOI
ScienceOn
|
37 |
Pan G, Ni J, Wei YF, Yu G, Gentz R, Dixit VM (1997): An antagonist decoy receptor and a death domain-containing receptor for TRAIL. Science 277:815-818
DOI
PUBMED
ScienceOn
|
38 |
Cohen GM (1997): Caspases: the executioners of apoptosis. Biochem J 326:1-16
DOI
|